Literature DB >> 30981888

IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.

Akira Kurozumi1, Kazuhisa Nakano1, Kaoru Yamagata1, Yosuke Okada1, Shingo Nakayamada1, Yoshiya Tanaka2.   

Abstract

Inflammation and vascular calcification are independent risk factors of cardiovascular events. Vascular smooth muscle cells (VSMCs) exhibit osteoblast-like characteristics in response to various stimuli such as oxidized cholesterol and inflammation. However the precise mechanism of transcriptional regulation of VSMCs by inflammatory stimuli remains unclear. We investigated the process and mechanisms of inflammatory cytokine-induced transformation of human VSMCs (hVSMCs) into osteoblast-like cells, with a special focus on epigenetic changes. Our results demonstrated: (1) interleukin-6 (IL-6)/soluble interleukin-6 receptor (sIL-6R) induced transformation of hVSMCs into an osteoblast phenotype, with subsequent vascular calcification, based on the results of Alizarin Red S staining and O-Cresolphthalein complexone method; (2) IL-6/sIL-6R accelerated the expression of runt-related transcription factor 2 (RUNX2) based on the results of quantitative real-time polymerase chain reaction; (3) Knockdown of signal transducer and activator of transcription (STAT) 3 reduced IL-6/sIL-6R-induced RUNX2 mRNA expression and osteoblast transdifferentiation of hVSMCs; (4) Chromatin immunoprecipitation (ChIP) coupled with PCR (ChIP-PCR) identified a STAT-binding site in RUNX2 promoter region containing trimethylated histone 3 lysine 9 (H3K9me3), a transcriptional repressor, and H3K4me3, a transcriptional enhancer. Stimulation with IL-6/sIL-6R suppressed H3K9me3 but not H3K4me3 through the recruitment of jumonji domain-containing protein (JMJD) 2B, a histone lysine demethylase, at the STAT-binding site in RUNX2 promoter region; (5) IL-6/sIL-6R-induced RUNX2 gene expression was inhibited in hVSMCs pretreated with JIB04, JMJD2 inhibitor, and the inhibitory effect was JIB04 dose-dependent. Our results indicate that the IL-6/STAT3/JMJD2B pathway regulates hVSMCs differentiation into osteoblast-like cells, which suggest its pathogenic role in vascular calcification associated with chronic inflammation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Disorders of calcium/phosphate; Epigenetics; Osteoblasts; Transcription factors

Year:  2019        PMID: 30981888     DOI: 10.1016/j.bone.2019.04.006

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  28 in total

1.  The microRNA-34a-Induced Senescence-Associated Secretory Phenotype (SASP) Favors Vascular Smooth Muscle Cells Calcification.

Authors:  Estella Zuccolo; Ileana Badi; Francesco Scavello; Irene Gambuzza; Luigi Mancinelli; Federica Macrì; Calogero C Tedesco; Fabrizio Veglia; Anna Rita Bonfigli; Fabiola Olivieri; Angela Raucci
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

2.  Phosphate Burden and Inflammation.

Authors:  Anna Sarah Erem; Satoko Osuka; Mohammed S Razzaque
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Lineage-specific rearrangement of chromatin loops and epigenomic features during adipocytes and osteoblasts commitment.

Authors:  Ruo-Han Hao; Yan Guo; Chen Wang; Fei Chen; Chen-Xi Di; Shan-Shan Dong; Qi-Long Cao; Jing Guo; Yu Rong; Shi Yao; Dong-Li Zhu; Yi-Xiao Chen; Hao Chen; Tie-Lin Yang
Journal:  Cell Death Differ       Date:  2022-07-29       Impact factor: 12.067

4.  Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement.

Authors:  Carmen Ciavarella; Ilenia Motta; Santino Blando; Sabrina Valente; Fulvia Farabegoli; Maria Letizia Focarete; Mauro Gargiulo; Gianandrea Pasquinelli
Journal:  Biomedicines       Date:  2022-05-30

Review 5.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

Review 6.  Histone Lysine Methylation Modification and Its Role in Vascular Calcification.

Authors:  Ye-Chi Cao; Su-Kang Shan; Bei Guo; Chang-Chun Li; Fu-Xing-Zi Li; Ming-Hui Zheng; Qiu-Shuang Xu; Yi Wang; Li-Min Lei; Ke-Xin Tang; Wen-Lu Ou-Yang; Jia-Yue Duan; Yun-Yun Wu; Muhammad Hasnain Ehsan Ullah; Zhi-Ang Zhou; Feng Xu; Xiao Lin; Feng Wu; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 7.  Mammalian Sirtuins and Their Relevance in Vascular Calcification.

Authors:  Xinyue Pan; Caixia Pi; Xianchun Ruan; Hanhua Zheng; Demao Zhang; Xiaoheng Liu
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

Review 8.  Innate and adaptive immunity in cardiovascular calcification.

Authors:  Livia S A Passos; Adrien Lupieri; Dakota Becker-Greene; Elena Aikawa
Journal:  Atherosclerosis       Date:  2020-02-28       Impact factor: 5.162

Review 9.  The Epigenetic Landscape of Vascular Calcification: An Integrative Perspective.

Authors:  Yi-Chou Hou; Chien-Lin Lu; Tzu-Hang Yuan; Min-Tser Liao; Chia-Ter Chao; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2020-02-01       Impact factor: 5.923

Review 10.  Vascular Calcification-New Insights Into Its Mechanism.

Authors:  Sun Joo Lee; In-Kyu Lee; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.